These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16551439)

  • 1. Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis.
    Perrella O; Sbreglia C; Perrella M; Spetrini G; Gorga F; Pezzella M; Perrella A; Atripaldi L; Carrieri P
    Neurol Res; 2006 Mar; 28(2):193-5. PubMed ID: 16551439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis: a correlation with clinical activity.
    Carrieri PB; Provitera V; De Rosa T; Tartaglia G; Gorga F; Perrella O
    Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):373-82. PubMed ID: 9736442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of interferon-beta on interleukin-10 in multiple sclerosis patients.
    Ersoy E; Kuş CN; Sener U; Coker I; Zorlu Y
    Eur J Neurol; 2005 Mar; 12(3):208-11. PubMed ID: 15693810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
    Shi N; Kawano Y; Matsuoka T; Mei F; Ishizu T; Ohyagi Y; Kira J
    Mult Scler; 2009 Jan; 15(1):120-3. PubMed ID: 18755820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis.
    Al-Shammri S; Rawoot P; Azizieh F; AbuQoora A; Hanna M; Saminathan TR; Raghupathy R
    J Neurol Sci; 2004 Jul; 222(1-2):21-7. PubMed ID: 15240191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenetic cytokine restriction in multiple sclerosis].
    Odinak MM; Bisaga GN; kalinina NM; Akimov SB; Davydova NI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(9):39-44. PubMed ID: 11586702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
    Blauth K; Zhang X; Chopra M; Rogan S; Markovic-Plese S
    Clin Immunol; 2015 Apr; 157(2):121-32. PubMed ID: 25596452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.
    Benvenuto R; Paroli M; Buttinelli C; Franco A; Barnaba V; Fieschi C; Balsano F
    Clin Exp Immunol; 1991 Apr; 84(1):97-102. PubMed ID: 2015713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.
    Brucklacher-Waldert V; Stuerner K; Kolster M; Wolthausen J; Tolosa E
    Brain; 2009 Dec; 132(Pt 12):3329-41. PubMed ID: 19933767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
    Nakajima H; Fukuda K; Doi Y; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
    Eur Neurol; 2004; 52(3):162-8. PubMed ID: 15528917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.